David Snyder
Analyst
Private Investor
Board Member
Coya Therapeutics, Inc. (COYA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-01-01–present
-
Private Investor
Analyst
Source not stated
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Coya Therapeutics, Inc. (COYA) | Chief Financial Officer and Chief Operating Officer | $442,000 | $1,368,700 |
| 2024 | Coya Therapeutics, Inc. (COYA) | Chief Financial Officer and Chief Operating Officer | $425,000 | $1,465,084 |
| 2023 | Coya Therapeutics, Inc. (COYA) | Chief Financial Officer and Chief Operating Officer | $425,000 | $947,888 |
| 2022 | Coya Therapeutics, Inc. (COYA) | Chief Financial Officer and Chief Operating Officer | $279,775 | $608,521 |
| 2021 | Coya Therapeutics, Inc. (COYA) | Chief Financial Officer and Chief Operating Officer | — | — |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.